Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification

BACKGROUND: Adalimumab blocks the action of tumor necrosis factor-α and reduces disease progression in rheumatoid arthritis and psoriatic arthritis. The effects of adalimumab in controlling progression of structural damage in erosive hand osteoarthritis (HOA) were assessed. METHODS: Sixty patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Verbruggen, Gust, Wittoek, Ruth, Cruyssen, Bert Vander, Elewaut, Dirk
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2011
Assuntos:
Clinical and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3371224/
https://ncbi.nlm.nih.gov/pubmed/22128078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2011.149849
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados